These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6456007)

  • 1. Inhibition of gamma-aminobutyric acid transaminase with 6-aminonicotinamide in regions of the rat brain.
    Prakash MR; Baouer NZ
    Biochem Pharmacol; 1981 Mar; 30(6):663-4. PubMed ID: 6456007
    [No Abstract]   [Full Text] [Related]  

  • 2. Thiopental inhibition of gamma-aminobutyrate transminase in rat brain synaptosomes.
    Cheng SC; Brunner EA
    Biochem Pharmacol; 1979; 28(1):105-9. PubMed ID: 758900
    [No Abstract]   [Full Text] [Related]  

  • 3. N-(5'-Phosphopyridoxyl)-4-aminobutyric acid: a stabel bisubstrate adduct inhibitor of rat brain 4-aminobutyric acid aminotransferase.
    Tunnicliff G; Ngo TT; Barbeau A
    Experientia; 1977 Jan; 33(1):20-2. PubMed ID: 836410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Aminobutyric acid metabolism in rat brain following chronic oral administration of ethanolamine O-sulphate.
    Fletcher A; Fowler LJ
    Biochem Pharmacol; 1980 Jun; 29(11):1451-4. PubMed ID: 7396979
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo inactivation of gamma-aminobutyric acid-alpha-ketoglutarate transaminase by 4-amino-5-fluoropentanoic acid.
    Silverman RB; Levy MA; Muztar AJ; Hirsch JD
    Biochem Biophys Res Commun; 1981 Sep; 102(1):520-3. PubMed ID: 7306169
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme-activated irreversible inhibition of rat and mouse brain 4-aminobutyric acid-alpha-ketoglutarate transaminase by 5-fluoro-4-oxo-pentanoic acid.
    Lippert B; Metcalf BW; Resvick RJ
    Biochem Biophys Res Commun; 1982 Sep; 108(1):146-52. PubMed ID: 7150278
    [No Abstract]   [Full Text] [Related]  

  • 7. The irreversible inhibition of mouse brain gamma-aminobutyric acid (GABA)-alpha-ketoglutaric acid transaminase by gabaculine.
    Rando RR; Bangerter FW
    J Am Chem Soc; 1976 Oct; 98(21):6762-4. PubMed ID: 972233
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of 6-aminonicotinamide on the levels of brain amino acids and glucose, and their labeling with 14C after injection of [U-14C] glucose.
    Gaitonde MK; Lewis LP; Evans G; Clapp A
    Neurochem Res; 1981 Oct; 6(10):1159-67. PubMed ID: 6121299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase.
    van der Laan JW; de Boer T; Bruinvels J
    J Neurochem; 1979 Jun; 32(6):1769-80. PubMed ID: 376783
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible inactivation of pig brain gamma-aminobutyric acid-alpha-ketoglutarate transaminase by 4-amino-5-halopentanoic acids.
    Silverman RB; Levy MA
    Biochem Biophys Res Commun; 1980 Jul; 95(1):250-5. PubMed ID: 7417253
    [No Abstract]   [Full Text] [Related]  

  • 11. 4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain.
    Lippert B; Metcalf BW; Jung MJ; Casara P
    Eur J Biochem; 1977 Apr; 74(3):441-5. PubMed ID: 856582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo inhibition of GABA-transaminase by gabaculine.
    Rando RR; Bangerter FW
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1276-81. PubMed ID: 901477
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gamma-aminobutyric acid system in the cat brain during convulsions].
    Snisar' IA; Orekhov VS; Sytinskiĭ IA
    Vopr Med Khim; 1982; 28(5):60-3. PubMed ID: 7179835
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of glucose into glutamate via the hexose monophosphate shunt and its inhibition by 6-aminonicotinamide in rat brain in vivo.
    Gaitonde MK; Jones J; Evans G
    Proc R Soc Lond B Biol Sci; 1987 Jun; 231(1262):71-90. PubMed ID: 2888118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for the existence of isozymes of brain gamma-aminobutyrate aminotransferase.
    Ngo TT; Tunnicliff G
    Comp Biochem Physiol C Comp Pharmacol; 1978; 59(2):101-4. PubMed ID: 25733
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative pathways of glucose utilization in brain; changes in the pattern of glucose utilization in brain resulting from treatment of rats with 6-aminonicotinamide.
    Hothersall JS; Zubairu S; McLean P; Greenbaum AL
    J Neurochem; 1981 Dec; 37(6):1484-96. PubMed ID: 6460850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA.
    Löscher W
    J Neurochem; 1980 Jun; 34(6):1603-8. PubMed ID: 7381487
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide.
    Krieglstein J; Stock R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):323-7. PubMed ID: 127127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the kinetics of the inhibition of rabbit brain gamma-aminobutyrate aminotransferase by sodium n-dipropylacetate and some other simple carboxylic acids.
    Fowler LJ; Beckford J; John RA
    Biochem Pharmacol; 1975 Jul; 24(13-14):1267-70. PubMed ID: 1096898
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of 6-aminonicotinamide on monoamine oxidase and Na+K+ATPase activity in different regions of rat brain.
    Mayanil CK; Kazmi SM; Baquer NZ
    Biochem Pharmacol; 1984 Oct; 33(19):3021-3. PubMed ID: 6091665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.